Cargando…

Therapy with direct oral anticoagulants for secondary prevention of thromboembolic events in the antiphospholipid syndrome: a systematic review and meta-analysis of randomised trials

OBJECTIVE: Antiphospholipid syndrome (APS) is a systemic autoimmune disorder characterised by venous thrombosis (VT) or arterial thrombosis (AT) and/or pregnancy morbidity and the presence of antiphospholipid antibodies. Direct oral anticoagulants (DOACs) hold several advantages to vitamin K antagon...

Descripción completa

Detalles Bibliográficos
Autores principales:	Adelhelm, Josefine B H, Christensen, Robin, Balbi, Gustavo G M, Voss, Anne
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2023
Materias:	Reproductive health and APS
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10619019/ https://www.ncbi.nlm.nih.gov/pubmed/37899090 http://dx.doi.org/10.1136/lupus-2023-001018

Ejemplares similares

Pregnancy outcomes in antiphospholipid antibody positive patients: prospective results from the AntiPhospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networking (APS ACTION) Clinical Database and Repository (‘Registry’)
por: Erton, Zeynep Belce, et al.
Publicado: (2022)

Effectiveness of a multidisciplinary clinical pathway for women with systemic lupus erythematosus and/or antiphospholipid syndrome
por: Wind, Merlijn, et al.
Publicado: (2021)

Increased usage of special educational services by children born to mothers with systemic lupus erythematosus and antiphospholipid antibodies
por: Marder, Wendy, et al.
Publicado: (2014)

Lupus anticoagulant, disease activity and low complement in the first trimester are predictive of pregnancy loss
por: Mankee, Anil, et al.
Publicado: (2015)

Characteristics related to early secondary amenorrhoea and pregnancy among women diagnosed with systemic lupus erythematosus: an analysis using the GOAL study
por: Knight, Jessica H, et al.
Publicado: (2016)

Adverse pregnancy outcomes and subsequent risk of cardiovascular disease in women with systemic lupus erythematosus
por: Lin, Pin, et al.
Publicado: (2014)

Pregnancy outcomes among African–American patients with systemic lupus erythematosus compared with controls
por: Barnado, April, et al.
Publicado: (2014)

Placental histology and neutrophil extracellular traps in lupus and pre-eclampsia pregnancies
por: Marder, Wendy, et al.
Publicado: (2016)

Anti-Müllerian hormone in African-American women with systemic lupus erythematosus
por: Angley, Meghan, et al.
Publicado: (2020)

Breastfeeding in women with rheumatic diseases
por: Ikram, Naira, et al.
Publicado: (2021)

Hydroxychloroquine PK and exposure-response in pregnancies with lupus: the importance of adherence for neonatal outcomes
por: Balevic, Stephen J, et al.
Publicado: (2022)

Impact of pregnancy in patients with systemic lupus erythematosus-associated pulmonary arterial hypertension: case series and literature review
por: Li, Mucong, et al.
Publicado: (2022)

Hydroxychloroquine in the pregnancies of women with lupus: a meta-analysis of individual participant data
por: Clowse, Megan E B, et al.
Publicado: (2022)

Recommendations for rapid sequence induction in Europe – How standardized is the standard of care?
por: Wetsch, Wolfgang, et al.
Publicado: (2013)

Direct oral anticoagulants in antiphospholipid syndrome with venous thromboembolism: Impact of the European Medicines Agency guidance
por: Fazili, Masarret, et al.
Publicado: (2019)

Direct oral anticoagulants and venous thromboembolism
por: Franchini, Massimo, et al.
Publicado: (2016)

Role of Direct Oral Anticoagulation Agents as Thromboprophylaxis in Antiphospholipid Syndrome
por: Arora, Shreya, et al.
Publicado: (2021)

Successful secondary thromboprophylaxis with direct oral anticoagulants for a patient with catastrophic antiphospholipid syndrome: A case report
por: Dinh, Nhan Hieu, et al.
Publicado: (2020)

Recurrent life-threatening thromboembolism and catastrophic antiphospholipid syndrome in a patient despite sufficient oral anticoagulation
por: Miesbach, W., et al.
Publicado: (2004)

Anticoagulant treatment satisfaction with warfarin and direct oral anticoagulants for venous thromboembolism
por: Fang, Margaret C., et al.
Publicado: (2021)

Atypical Findings of Focal Nodular Hyperplasia with Gadoxetic Acid (Gd-EOB-DTPA)-Enhanced Magnetic Resonance Imaging
por: Yoon, Jung-Hee, et al.
Publicado: (2014)

Estado actual de los tratamientos para la COVID-19
por: Llover, Mariona Nadal, et al.
Publicado: (2021)

Mantenimiento de tratamientos crónicos en pacientes afectados de COVID-19
por: Sánchez, Jesús M. Redondo, et al.
Publicado: (2021)

Lack of efficacy of direct oral anticoagulants compared to warfarin in antiphospholipid antibody syndrome
por: Giarretta, Igor, et al.
Publicado: (2022)

Direct Oral Anticoagulants and Travel-related Venous Thromboembolism
por: Chamnanchanunt, Supat, et al.
Publicado: (2018)

Direct Oral Anticoagulants for the Treatment of Venous Thromboembolism in Japan
por: Nakamura, Mashio, et al.
Publicado: (2017)

Direct oral anticoagulants for unusual‐site venous thromboembolism
por: Riva, Nicoletta, et al.
Publicado: (2021)

Direct Oral Anticoagulants for Cancer-Associated Venous Thromboembolism
por: Masini, Marta, et al.
Publicado: (2023)

Direct Oral Anticoagulants or Standard Anticoagulant Therapy in Fragile Patients with Venous Thromboembolism
por: López-Núñez, Juan J., et al.
Publicado: (2019)

Antiphospholipid Syndrome Secondary to Lupus Anticoagulant: Case Report for Clinical Anticoagulation Determination
por: Lambroussis, Constantino G, et al.
Publicado: (2022)

Direct oral anticoagulants in the treatment of cancer-associated venous thromboembolism
por: Yhim, Ho-Young, et al.
Publicado: (2014)

Use of direct oral anticoagulants for chronic thromboembolic pulmonary hypertension
por: Gavilanes-Oleas, Francisca Alexandra, et al.
Publicado: (2018)

Direct oral anticoagulants for the treatment of venous thromboembolism in patients with cancer
por: Planquette, Benjamin, et al.
Publicado: (2019)

Thromboembolic Antiphospholipid Syndrome (APS): Efficacy and Safety of Different Anticoagulants-Results of the APSantiCO Registry
por: Schulz, Annabel, et al.
Publicado: (2022)

Direct-Acting Oral Anticoagulants as Prophylaxis Against Thromboembolism in the Nephrotic Syndrome
por: Sexton, Donal J., et al.
Publicado: (2018)

Direct oral anticoagulants for treatment and prevention of venous thromboembolism in cancer patients
por: Song, Andrew B, et al.
Publicado: (2019)

Treatment of cancer-associated venous thromboembolism in the age of direct oral anticoagulants
por: Ay, C, et al.
Publicado: (2019)

Recent advances in the treatment of venous thromboembolism in the era of the direct oral anticoagulants
por: Weitz, Jeffrey I., et al.
Publicado: (2017)

The Use of Direct Oral Anticoagulants in the Management of Venous Thromboembolism in Patients With Obesity
por: Younis, Moustafa, et al.
Publicado: (2020)

The role of direct oral anticoagulants in venous thromboembolic disease in gynecologic cancer
por: Park, Jeong-Yeol
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_n21v92qcmkg0al10mpkf7n6c3b